BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+2.62%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.86B
AUM Growth
+$2.86B
Cap. Flow
+$148M
Cap. Flow %
5.18%
Top 10 Hldgs %
48.6%
Holding
107
New
11
Increased
2
Reduced
2
Closed
19

Top Buys

1
TYRA icon
Tyra Biosciences
TYRA
$111M
2
TNGX icon
Tango Therapeutics
TNGX
$88.9M
3
BPMC
Blueprint Medicines
BPMC
$43.7M
4
FULC icon
Fulcrum Therapeutics
FULC
$35.3M
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$34.9M

Top Sells

1
SGEN
Seagen Inc. Common Stock
SGEN
$63.2M
2
AMRN
Amarin Corp
AMRN
$26.3M
3
KDMN
Kadmon Holdings, Inc.
KDMN
$24M
4
AGEN
Agenus
AGEN
$22M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
$20.9M

Sector Composition

1 Healthcare 98.16%
2 Financials 0.75%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MLTX icon
76
MoonLake Immunotherapeutics
MLTX
$3.75B
$3.98M 0.14%
400,000
– –
OBIO icon
77
Orchestra BioMed
OBIO
$146M
$3.96M 0.14%
400,000
– –
LJPC
78
DELISTED
La Jolla Pharmaceutical Company
LJPC
$3.55M 0.12%
890,700
– –
KNSA icon
79
Kiniksa Pharmaceuticals
KNSA
$2.61B
$3.31M 0.12%
290,577
– –
LABD icon
80
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$61M
$3.2M 0.11%
+150,000
New +$3.2M
GNCA
81
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.18M 0.08%
1,134,453
– –
SNCE
82
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$1.96M 0.07%
200,000
– –
OMEG
83
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$1.95M 0.07%
200,000
– –
TARA icon
84
Protara Therapeutics
TARA
$124M
$1.45M 0.05%
209,227
– –
SRZN icon
85
Surrozen
SRZN
$109M
$1.42M 0.05%
+200,000
New +$1.42M
CLRB icon
86
Cellectar Biosciences
CLRB
$15.4M
$851K 0.03%
920,000
– –
NUVB.WS icon
87
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$66.5M
$683K 0.02%
266,666
– –
AGEN
88
Agenus
AGEN
$135M
– –
-4,000,000
Closed -$22M
AMRN
89
Amarin Corp
AMRN
$315M
– –
-6,000,000
Closed -$26.3M
ATXS icon
90
Astria Therapeutics
ATXS
$387M
– –
-1,775,000
Closed -$3.75M
BMRN icon
91
BioMarin Pharmaceuticals
BMRN
$11.3B
– –
-250,000
Closed -$20.9M
BOLT icon
92
Bolt Biotherapeutics
BOLT
$9.29M
– –
-50,000
Closed -$773K
ESPR icon
93
Esperion Therapeutics
ESPR
$478M
– –
-500,000
Closed -$10.6M
IMVT icon
94
Immunovant
IMVT
$2.87B
– –
-1,000,000
Closed -$10.6M
MIRM icon
95
Mirum Pharmaceuticals
MIRM
$3.72B
– –
-317,000
Closed -$5.48M
MREO
96
Mereo BioPharma
MREO
$275M
– –
-6,226,673
Closed -$19.7M
MRNA icon
97
Moderna
MRNA
$9.31B
– –
0
– –
MTNB icon
98
Matinas BioPharma
MTNB
$10.2M
– –
-11,478,634
Closed -$8.9M
QURE icon
99
uniQure
QURE
$946M
– –
-250,000
Closed -$7.7M
SYRE icon
100
Spyre Therapeutics
SYRE
$1.01B
– –
-550,000
Closed -$3.83M
1 2 3
4
5